Bayesian Approaches to Randomized Trials
From MaRDI portal
Publication:4785356
DOI10.2307/2983527zbMath1001.62529OpenAlexW1991058132MaRDI QIDQ4785356
Mahesh K. B. Parmar, Laurence S. Freedman, David J. Spiegelhalter
Publication date: 1 January 2003
Published in: Journal of the Royal Statistical Society. Series A (Statistics in Society) (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2983527
Related Items
Prediction markets, Bayesian priors, and clinical trials, Optimal sampling for repeated binary measurements, Optimal healthcare decisions: comparing medical treatments on a cost-effectiveness basis, Bayesian techniques for sample size determination in clinical trials: a short review, Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?, Reflections on Fourteen Cryptic Issues Concerning the Nature of Statistical Inference*, A Bayesian approach to Weibull survival models -- application to a cancer clinical trial, Clinician preferences and the estimation of causal treatment differences. (With comments), Determining the Effective Sample Size of a Parametric Prior, Incorporating external information in analyses of clinical trials with binary outcomes, Bayesian and likelihood inference for cure rates based on defective inverse Gaussian regression models, Bayesian models and methods in public policy and government settings, Implementing Bayesian predictive procedures: the \(K\)-prime and \(K\)-square distributions, Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design, Why should clinicians care about Bayesian methods? (With discussions and response), Biostatistics in the new millennium: a consulting statistician's perspective, Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go?, Ethical considerations concerning treatment allocation in drug development trials, Incorporating Bayesian ideas into health-care evaluation, Bayesian statistics and the efficiency and ethics of clinical trials, Hierarchical Proportional Hazards Regression Models for Highly Stratified Data, Approximate Bayesian Evaluation of Multiple Treatment Effects, A Bayesian Group Sequential Approach for Multiple Endpoints, A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials, Bayesian Evidence Accumulation in Experimental Mathematics: A Case Study of Four Irrational Numbers, Rejoinder: Approximate models and robust decisions, Simulation-based sequential Bayesian design, Unnamed Item, Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests, Case-Control Analysis with Partial Knowledge of Exposure Misclassification Probabilities, Bayesian index to compare assumed survival functions of two hazards following exponential distributions, Conservative prior distributions for variance parameters in hierarchical models, Two useful distributions for Bayesian predicitve procedures under normal models, Interpreting \(p\)-values and confidence intervals using well-calibrated null preference priors, Bayesian approach to determine the number of subsequent users of a new treatment, The Performance of Random Coefficient Regression in Accounting for Residual Confounding, Applying non-parametric robust Bayesian analysis to non-opinionated judicial neutrality, Treatment Choice With Trial Data: Statistical Decision Theory Should Supplant Hypothesis Testing, Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II
